Cytogen (CYTO) Hires ThinkEquity Partners To Evaluate Strategic Alternatives
More News related to CYTO
- Cytogen (CYTO) Hires ThinkEquity Partners To Evaluate Strategic Alternatives
- Cytogen (CYTO): Outcomes Data Demonstrating Prognostic Value of PROSTASCINT
- Cytogen Corporation (CYTO) Reports Updated Data From a Phase 1 Dose Escalation Study Evaluating QUADRAMET
- Cytogen (CYTO) Announces $20 Million Private Placement
- Cytogen (CYTO) Acquires North American Rights to CAPHOSOL
More News related to Corporate News
- Google Unveils 'Buzz' Social Sharing Tool
- Semiconductor Manufacturing Int (SMI) Confirms Seeking Alternatives for Company; No Definite Decision Made
- Highlights From KO's Q4 Conference Call: Continued Solid Growth Globally in Several Segments
- Toyota's (TM) Hearing in House on Recalls Moved to Feb. 24
- Marathon Oil (MRO) Sells 20% Undivided Interest in Angola Block 32
Cytogen Corporation (NASDAQ: CYTO) engaged ThinkEquity Partners LLC, to assist the Company in identifying and evaluating strategic alternatives intended to enhance the future growth potential of the Company’s pipeline and maximize shareholder value.
Related Categories
Corporate NewsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
